Why Is Vanda Pharmaceuticals Stock Trading Higher Today?

Vandana Singh | April 3, 2024

Tuesday, the FDA approved Vanda Pharmaceuticals Inc’s (NASDAQ:VNDA) Fanapt (iloperidone) tablets for the acute treatment of manic or mixed episodes associated with bipolar I disorder in adults. Fanapt is an atypical antipsychotic agent that has been used for the acute treatment of patients with schizophrenia since its FDA approval in 2009. Bipolar disorder is a psychiatric chronic condition […]

Wait! Before you go...

Always be feeding your money brain. Claim one or all of the FREE offers from some of our partners below.

x